Cognitive Impairment and Dementia in Parkinson's DiseaseMurat Emre OUP Oxford, 8 thg 1, 2015 - 320 trang In this edited volume, experts on the treatment of dementia associated with Parkinson's Disease (PD) describe in detail the current status of knowledge in their respective area of expertise. The importance and clinical relevance of cognitive impairment and dementia in PD is emphasized, all relevant aspects including epidemiology, full and detailed spectrum of clinical features, current knowledge on pathology, neurochemistry and genetics, findings in auxillary investigations, relation to other neurodegenerative disorders, diagnostic process and management are described, rounded-up by discussion of future research directions and expectations. The text is complemented and enriched with tables, figures and is heavily referenced thereby capturing all relevant literature. |
Nội dung
Cognitive profile in Parkinsons disease dementia | |
Neuropsychiatric symptoms in Parkinsons disease | |
Interaction between affect and executive functions | |
disease dementia | |
Biomarkers for cognitive impairment and dementia | |
Electrophysiological and other auxiliary investigations | |
Pathological correlates of dementia in Parkinsons disease | |
Epidemiology diagnosis and correlates of mild cognitive | |
The pathophysiological and prognostic heterogeneity of mild | |
relationship | |
Spectrum of disorders with dementia and parkinsonism | |
Diagnosis of dementia in Parkinsons disease | |
Management of Parkinsons disease dementia | |
what will the future bring? | |
The genetic basis of dementia in Parkinsons disease | |
Neurochemical pathology of Parkinsons disease dementia | |
Ấn bản in khác - Xem tất cả
Thuật ngữ và cụm từ thông dụng
Aarsland alpha-synuclein Alzheimer Alzheimer’s disease Ann Neurol apathy Arch Neurol assessment baseline behavioural biomarkers Brain cholinergic clinical cognitive decline cognitive deficits cognitive dysfunction cognitive function cohort compared controls correlates cortex cortical criteria dementia in Parkinson’s dementia with Lewy depression develop dementia diagnosis disease with dementia DLB and PDD DLB patients donepezil dopamine dopaminergic dualtasking executive function followup frontal gait gene genetic glucocerebrosidase impairment in Parkinson’s Larsen JP levodopa Lewy body dementia Lewy body disease longitudinal study LRRK2 MAPT memory mild cognitive impairment MMSE Mov Disord 2006 multiple system atrophy mutations Neurol Neurosurg Psychiatry Neurology Neuropathol neuropsychological Neurosci onset Parkinson’s disease Parkinson’s disease dementia parkinsonian Parkinsonism Relat Disord pathology patients with Parkinson’s patients with PD patients without dementia PD patients PDD PDD and DLB PDMCI progressive supranuclear palsy psychosis receptors reported risk factors rivastigmine scores subtype syndrome tasks tests treatment visual hallucinations visuospatial